Anti-HIV Drug Development - An Overview

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|32|4005-4037

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.32, 2004-12, pp. : 4005-4037

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Calixarenes, Cyclodextrins and Fullerenes as New Platforms for Anti-HIV Drug Design: An Overview

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-06 ,pp. : 1160-1165

Bentham Science Publishers

Access to resources Recommend Favorite

Application of 3D-QSAR Techniques in Anti-HIV-1 Drug Design - An Overview

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3091-3110

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1767-1783

Bentham Science Publishers

Access to resources Recommend Favorite

Off-label indication: acyclovir as an anti-HIV drug?

By Vanpouille Christophe   Lisco Andrea   Margolis Leonid  

Future Virology, Vol. 4, Iss. 1, 2009-01 ,pp. : 1-5

Future Medicine

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite